Related Experiment Videos

Resistance to human immunodeficiency virus type 1 protease inhibitors

D Boden¹, M Markowitz

¹Aaron Diamond AIDS Research Center, New York, New York 10016, USA.

Antimicrobial Agents and Chemotherapy

|October 31, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States.

AIDS and behavior·2018

The prevalence of vitamin D deficiency and its relationship with disease severity in an urban pediatric critical care unit.

Endocrine regulations·2014

Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.

The Journal of experimental medicine·2001

New antiretroviral may help failing PI regimens.

AIDS alert·2001

Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1--infected patients.

Journal of acquired immune deficiency syndromes (1999)·2001

Short-term measures of relative efficacy predict longer-term reductions in human immunodeficiency virus type 1 RNA levels following nelfinavir monotherapy.

Antimicrobial agents and chemotherapy·2001

See all related articles